Egyptian Heart Journal最新文献

{"title":"Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients","authors":"Haitham Galal Mohammed,&nbsp;Adel Mohamed Shabana","doi":"10.1016/j.ehj.2018.02.004","DOIUrl":"10.1016/j.ehj.2018.02.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Cardiac rehabilitation improves disease-related symptoms, quality of life, and clinical outcomes. This study was done to evaluate the effect of cardiac rehabilitation program on cardiovascular risk factors in chronic heart failure patients as well as functional capacity and health related quality of life.</p></div><div><h3>Methods</h3><p>The study was conducted on 80 Patients with chronic stable heart failure. All patients had full history and thorough physical examination. Body mass index (BMI), waist circumference, glycated hemoglobin (HbA1c), lipid profile, and echocardiography, all of which were done before and after recruitment in a 2 months cardiac rehabilitation program (through prescribed exercise training, 2 sessions/week for 2 months). The changes in functional capacity were evaluated by 6-min walk test (6MWT) and the changes in the health related quality of life were measured by Minnesota living with heart failure questionnaire (MLHFQ), both were done before and after the rehabilitation program.</p></div><div><h3>Results</h3><p>There was a highly significant reduction in the blood pressure, heart rate, BMI, waist circumference, the smokers’ number and the glycated hemoglobin (HbA1c) (P &lt; 0.01). However, there was no statistically significant reductions in low density lipoproteins (LDL), Triglycerides (P &gt; 0.05). Highly significant improvements were noted in the functional capacity and the health related quality of life as evidenced by improvement in the 6MWT and the MLHFQ scores (total score, physical and psychological domains, P &lt; 0.01).</p></div><div><h3>Conclusion</h3><p>Cardiac rehabilitation had a significant improvement of cardiovascular risk factors, functional capacity and Health related quality of life in patients with chronic heart failure.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 77-82"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2018.02.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting?","authors":"Amr A. Abdelwahab ,&nbsp;Ayman M. Elsaied","doi":"10.1016/j.ehj.2018.01.002","DOIUrl":"10.1016/j.ehj.2018.01.002","url":null,"abstract":"<div><h3>Background</h3><p>Angina symptom in patients with ischemic cardiomyopathy (ICM) after coronary artery bypass grafting (CABG) surgery is a major challenging problem in practice. The choice among different treatment modalities available can be judged by different parameters especially measuring the risk/cost ratio to achieve the benefit. Enhanced external counter pulsation (EECP) is one of safest noninvasive modality for treatment of angina as well as it has an anti-failure effect.</p></div><div><h3>Patients and method</h3><p>42 patients with ICM after CABG were suffering from stable angina and were treated at Al-Hayat Cardiology Centre in Tanta City (ACC). 20 patients of them (group A) received 35 sessions of EECP plus their anti-ischemic and anti-failure treatment, while the other 22 patients (group B) received only medical treatment and were followed up for 3 months regarding their angina class, functional class, frequency of angina attack, frequency of sublingual nitrate and rate of rehospitalization when needed during follow up period.</p></div><div><h3>Results</h3><p>Despite both groups had nearly similar severity of symptoms regarding the CCS class and NYHA class, yet patients in group A experienced significant improvement in comparison to patients in group B (p-value = .005, p-value = .002 respectively), and this was reflected on frequency of angina and need for sublingual nitrates per week which showed significant decrease in group A (p-value = .001).</p></div><div><h3>Conclusion</h3><p>As a non-invasive treatment modality EECP is very effective in improving the symptoms of angina and heart failure when combined with medical treatment in patients with ICM after CABG.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 119-123"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2018.01.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Difference in plaque characteristics of coronary culprit lesions in a cohort of Egyptian patients presented with acute coronary syndrome and stable coronary artery disease: An optical coherence tomography study","authors":"Amr ElFaramawy ,&nbsp;Mina Youssef ,&nbsp;Mohamed Abdel Ghany ,&nbsp;Khaled Shokry","doi":"10.1016/j.ehj.2017.12.002","DOIUrl":"10.1016/j.ehj.2017.12.002","url":null,"abstract":"<div><h3>Aims</h3><p>This study was designed to utilize frequency-domain optical coherence tomography (FD-OCT) for assessment of plaque characteristics and vulnerability in patients with acute coronary syndrome (ACS) compared to stable coronary artery disease (SCAD).</p></div><div><h3>Methods and results</h3><p>We enrolled 48 patients; divided into an ACS-group (27 patients) and SCAD-group (21 patients) according to their clinical presentation. Hypertension and diabetes mellitus were more prevalent in SCAD group. Patients with ACS showed higher frequency of lipid-rich plaques (96.3% vs. 66.7%, P = .015), lower frequency of calcium plaques (7.4% vs. 57.1%, P &lt; .001), and fibrous plaques (14.8% vs. 81%, P &lt; .001) when compared with SCAD patients. The TCFA (defined as lipid-rich plaque with cap thickness &lt;65 μm) identified more frequently (33.3% vs. 14.3%, P = .185), with a trend towards thinner median fibrous cap thickness (70 (50–180) µm vs. 100 (50–220) µm, P = .064) in ACS group. Rupture plaque (52% vs. 14.3%, P = .014), plaque erosion (18.5% vs. 0%, P = .059) and intracoronary thrombus (92.6% vs. 14.3%, P &lt; .001) were observed more frequently in ACS group, while cholesterol crystals were identified frequently in patients with SCAD (0.0% vs. 33.3%, P = .002).</p></div><div><h3>Conclusion</h3><p>The current FD-OCT study demonstrated the differences of plaque morphology and identified distinct lesion characteristics between patients with ACS and those with SCAD. These findings could explain the clinical presentation of patients in both groups.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 95-100"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography","authors":"Ahmed Shawky Elserafy,&nbsp;Nireen Okasha,&nbsp;Tamim Hegazy","doi":"10.1016/j.ehj.2017.12.004","DOIUrl":"10.1016/j.ehj.2017.12.004","url":null,"abstract":"<div><h3>Background</h3><p>Contrast-induced nephropathy (CIN) is the acute deterioration of renal function after parenteral administration of radio contrast media in the absence of other causes. The true incidence of CIN varies because of differences among the published studies in the definition of CIN, the proportion of high-risk patients, the types of contrast media, and the use of preventive measures. Remote ischemic preconditioning (IPC) may offer a non-pharmacological prevention strategy for lowering CIN in patients undergoing coronary procedures. The assumption that IPC produces protective effects on tissues or organs by multiple brief cycles of ischemia and reperfusion applied to another remote tissue or organ.</p></div><div><h3>Aim</h3><p>To investigate the effect of ischemic preconditioning in prevention of CIN in patients with renal impairment undergoing percutaneous coronary angiography.</p></div><div><h3>Results</h3><p>In this study, 100 patients undergoing elective PCI with a base line creatinine clearance &lt;60 ml/min were studied. Patients were divided into two equal groups (ischemic preconditioning group and control group). The incidence of CIN was markedly lower in ischemic preconditioning group 14% VS 38% in control group. The incidence of CIN difference as was found to be (24%). Amount of dye used, decreased LVEF and presence of a significant LAD lesion were significant risk factors for occurrence of CIN.</p></div><div><h3>Conclusions</h3><p>The current study showed that remote ischemic preconditioning plays an important role in prevention of CIN in patients undergoing PCI with renal impairment GFR &lt; 60 ml/min. The amount of contrast, decreased LVEF, and presence of LAD significant lesion were significant risk factors for developing of CIN and these subgroups benefited from application of ischemic preconditioning.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 107-111"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.12.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous transluminal mitral valvuloplasty in post Mitral valve repair and Aortic valve replacement patient","authors":"Chandra Mani Adhikari ,&nbsp;Rabi Malla ,&nbsp;Raamesh Koirala ,&nbsp;Dipanker Prajapati ,&nbsp;Navin Gautam","doi":"10.1016/j.ehj.2017.11.001","DOIUrl":"10.1016/j.ehj.2017.11.001","url":null,"abstract":"<div><p>MV repair in the rheumatic population is feasible with acceptable long-term results. Incidence of mitral stenosis (MS) following mitral valve (MV) repair for severe rheumatic mitral regurgitation (MR) and usefulness of percutaneous transluminal mitral valvuloplasty in these patients is not described in literature. We report a case of successful PTMC in severe MS following MV repair for severe rheumatic MR.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 57-58"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction","authors":"Hossamaldin Zaki Alsayed Abuomara,&nbsp;Ossama Mohamed Hassan,&nbsp;Tarek Rashid,&nbsp;Mahmoud Baraka","doi":"10.1016/j.ehj.2017.12.001","DOIUrl":"10.1016/j.ehj.2017.12.001","url":null,"abstract":"<div><h3>Objectives</h3><p>To determine the value of Myocardial Performance Index (MPI) as an echocardiographic predictor of early in-hospital heart failure (HF) during first acute anterior ST-Elevation Myocardial Infarction (STEMI).</p></div><div><h3>Background</h3><p>Myocardial infarction induces variable degrees of impairment in left ventricular (LV) systolic and diastolic functions. The ejection fraction (EF) and transmitral flow, the most frequently used methods for evaluation of systolic and diastolic functions respectively, both have considerable limitations. The MPI is a single parameter, capable of estimating combined systolic and diastolic performance and lacks such limitations.</p></div><div><h3>Methods</h3><p>We enrolled 60 patients presented with a first acute anterior STEMI who have undergone primary PCI. Echocardiography was done within 24 h of chest pain with measurement of MPI. The LV MPI was calculated as (isovolumic contraction time “ICT” + relaxation time “IRT”)/Ejection time “ET”. Besides, clinical and echocardiographic variables were analyzed and CHF was defined as Killip class ≥ II.</p></div><div><h3>Results</h3><p>Early in-hospital HF occurred in 23 of patients (38%). Ejection fraction was found to have a highly significant negative correlation with the development of in-hospital HF (p = .0001), while MPI was found to have a highly significant positive correlation (p = .0001). A cut-off point of MPI &gt; 0.73 showed a very high specificity (94.6%) and sensitivity (78.3%) for identifying patients with HF. On the other hand, a cut-off point of EF ≤ 33% has shown 94.6% specificity and 56.5% sensitivity for HF prediction.</p></div><div><h3>Conclusions</h3><p>The MPI might be a strong predictor of in-hospital HF after first acute anterior STEMI.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 71-75"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.12.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content","authors":"Dalia Ragab,&nbsp;Khaled M. Taema,&nbsp;Waleed Farouk,&nbsp;Mohamed Saad","doi":"10.1016/j.ehj.2017.12.005","DOIUrl":"10.1016/j.ehj.2017.12.005","url":null,"abstract":"<div><h3>Introduction</h3><p>The administration of loop diuretics in the management of acute decompensated heart failure (ADHF) whether IV boluses or continuous infusion is still controversial. We intended to evaluate differences between the two administration routes on the thoracic fluid content (TFC) and the renal functions.</p></div><div><h3>Methods</h3><p>Sixty patients with ADHF admitted to the critical care medicine department (Cairo University, Egypt) were initially enrolled in the study. Twenty patients were excluded due to EF &gt; 40%, myocardial infarction within 30 days, and baseline serum creatinine level &gt; 4.0 mg/dL. Furosemide (120 mg/day) was given to the remaining 40 pts who continued the study after 1:1 randomization to either continuous infusion (group-I, 20 pts) or three equal intermittent daily doses (group-II, 20 pts). Subsequent dose titration was allowed after 24 h, but not earlier, according to patient’s response. No other diuretic medications were allowed. All patients were daily evaluated for NYHA class, urine output, TFC, body weight, serum K⁺, and renal chemistry.</p></div><div><h3>Results</h3><p>The median age (Q1–Q3) was 54.5 (43.8–63.8) years old with 24 (60%) males. Apart from TFC which was significantly higher in group-I, the admission demographic, clinical, laboratory and co-morbid conditions were similar in both groups. There was statistically insignificant tendency for increased urine output during the 1st and 2nd days in group-I compared to group-II (p = .08). The body weight was decreased during the 1st day by 2 (1.5–2.5) kg in group-I compared to 1.5 (1–2) kg in group-II, (p = .03). These changes became insignificant during the 2nd day (p = .4). The decrease of TFC was significantly higher in group-I than in group-II [10 (6.3–14.5) vs 7 (3.3–9.8) kΩ⁻¹ during the first day and 8 (6–11) vs 6 (3.3–8.5) kΩ⁻¹ during the second day in groups-I&amp;II respectively, P = .02 for both]. There was similar NYHA class improvement in both groups (p = .7). The serum creatinine was increased by 0.2 (0.1–0.5) vs 0 (−0.1 to 0.2) mg% and the CrCl was decreased by 7.4 (4.5–12.3) vs 3.1 (0.2–8.8) ml/min in groups-I&amp;II respectively (p = .009 and .02 respectively).</p></div><div><h3>Conclusions</h3><p>We concluded that continuous furosemide infusion in ADHF might cause greater weight loss and more decrease in TFC with no symptomatic improvement and possibly with more nephrotoxic effect.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 2","pages":"Pages 65-70"},"PeriodicalIF":1.1,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.12.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36449782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Double right coronary artery detected on coronary computed tomography angiography: A case report","authors":"Osman Mohamed Elfadil ,&nbsp;Yahya Mohamed Al Wahshi ,&nbsp;Ahmed Al Shamakhi","doi":"10.1016/j.ehj.2017.08.001","DOIUrl":"10.1016/j.ehj.2017.08.001","url":null,"abstract":"<div><p>Double right coronary artery is a relatively rare coronary anomaly. In this case report we aim to increase awareness of the importance of recognizing such anomaly and a brief literature review of similar cases and possible high risk features. Computed Tomography is well recognized modality to detect coronary anomaly and in our case we demonstrated this as well.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 51-53"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis","authors":"Mostafa Elwany ,&nbsp;Gaetano Di Palma ,&nbsp;Bernardo Cortese","doi":"10.1016/j.ehj.2017.12.006","DOIUrl":"10.1016/j.ehj.2017.12.006","url":null,"abstract":"","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 55-56"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.12.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The degree of hair graying as an independent risk marker for coronary artery disease, a CT coronary angiography study","authors":"Amr Abdel Aziz ElFaramawy,&nbsp;Irini Samuel Hanna,&nbsp;Reham Mohamed Darweesh,&nbsp;Ahmed Shehata Ismail,&nbsp;Hossam Ibrahim Kandil","doi":"10.1016/j.ehj.2017.07.001","DOIUrl":"10.1016/j.ehj.2017.07.001","url":null,"abstract":"<div><h3>Background</h3><p>Cardiovascular disease is a leading cause of death worldwide. Aging is an unavoidable coronary risk factor and is associated with dermatological signs that could be a marker for increased coronary risk. We tested the hypothesis that hair graying as a visible marker of aging is associated with risk of coronary artery disease (CAD) independent of chronological age.</p></div><div><h3>Methods</h3><p>This cross-sectional study included 545 males who underwent a computed tomography coronary angiography (CTCA) for suspicious of CAD, patients were divided into subgroups according to the percentage of gray/white hairs (Hair Whitening Score, HWS: 1–5) and to the absence or presence of CAD.</p></div><div><h3>Results</h3><p>CAD was prevalent in 80% of our studied population, 255 (46.8%) had 3 vessels disease with mean age of 53.2<!--> <!-->±<!--> <!-->10.7<!--> <!-->yrs. Hypertension, diabetes and dyslipidemia were more prevalent in CAD group (<em>P</em> <!-->=<!--> <!-->0.001, <em>P</em> <!-->=<!--> <!-->0.001, and <em>P</em> <!-->=<!--> <!-->0.003, respectively). Patients with CAD had statistically significant higher HWS (32.1% vs 60.1%, <em>p</em> <!-->&lt;<!--> <!-->0.001) and significant coronary artery calcification (&lt;0.001). Multivariate regression analysis showed that age (odds ratio (OR): 2.40, 95% confidence interval (CI): [1.31–4.39], <em>p</em> <!-->=<!--> <!-->0.004), HWS (OR: 1.31, 95% CI: [1.09–1.57], <em>p</em> <!-->=<!--> <!-->0.004), hypertension (OR: 1.63, 95% CI: [1.03–2.58], <em>p</em> <!-->=<!--> <!-->0.036), and dyslipidemia (OR: 1.61, 95% CI: [1.02–2.54], <em>p</em> <!-->=<!--> <!-->0.038) were independent predictors of the presence of atherosclerotic CAD, and only age (<em>p</em> <!-->&lt;<!--> <!-->0.001) was significantly associated with HWS.</p></div><div><h3>Conclusions</h3><p>Higher HWS was associated with increased coronary artery calcification and risk of CAD independent of chronological age and other established cardiovascular risk factors.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 15-19"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}